Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04751448 · ClinicalTrials.gov registry record
COLON-MD: Colon Cancer Longitudinal Study
A clinical trial of Colon Cancer, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT04751448: Recruiting study of Colon Cancer, sponsored by Baylor Research Institute.
NCT04751448 is a study of Colon Cancer that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 11 participants, below the 4,456-participant average among 97 other Colon Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04751448, a study of Colon Cancer, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
Primary Outcome
Microbiome analysis from at least 112 blinded samples will be conducted from fecal samples to determine sensitivity, specificity and accuracy (reported as percentage) of a microbiome-based predictor of chemotherapy-induced diarrhea in colon cancer.
Conditions Studied
Study Locations (1)
Texas
- Baylor Research Institute - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2026-06-01 |
What NCT04751448 shows while recruiting
NCT04751448 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 4,456-participant average among 97 other Colon Cancer trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Colon Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT04751448 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04751448 about?
NCT04751448 is a clinical study titled "COLON-MD: Colon Cancer Longitudinal Study". The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
What is the current status of trial NCT04751448?
This trial is currently recruiting. The enrollment target is 11 participants. The study started on 2021-02-01. Estimated completion is 2026-06-01.
What conditions does trial NCT04751448 study?
This clinical trial studies the following conditions: Colon Cancer.
Who is sponsoring clinical trial NCT04751448?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04751448 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04751448's enrollment target sits among peer trials
11 92nd of 97 higher than 4 of 97 other Colon Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colon Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
-
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
RECRUITING · Phase 1
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
-
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI